good news and bad news about Vioxx

The good news and bad news about Vioxx is creating questions.

Rheumatoid arthritis. Vioxx (rofecoxib) is now approved for symptoms of rheumatoid arthritis in adults... 25 mg once a day.

GI safety. The FDA now allows Merck to say that Vioxx reduces the risk of GI bleeding and perforations 50% compared to naproxen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote